Tumor necrosis factor-α induces caspase-independent cell death in human neutrophils via reactive oxidants and associated with calpain activity

Journal of Biomedical Science

Volumn 13, Issue 2, 2006, Pages 261-273

  Chen, Hao Cheng ^a   Wang, Chih Jan ^a   Chou, Chun Liang ^a   Lin, Shu Min ^a   Huang, Chien Da ^a   Lin, Ting Yu ^a   Wang, Chun Hua ^a   Lin, Horng Chyuan ^a   Yu, Chih Teng ^a   Kuo, Han Pin ^a   Liu, Chien Ying ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Calpain; Caspase; Neutrophil; Oxidant; Tumor necrosis factor

Indexed keywords

ANTIOXIDANT; CALPAIN; CALPASTATIN; CASPASE; DIMETHYL SULFOXIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LIPOCORTIN 5; PROPIDIUM IODIDE; PROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

AEROBIC METABOLISM; APOPTOSIS; ARTICLE; CELL DEATH; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MICROSCOPY; NEUTROPHIL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STAINING;

CALPAIN; CASPASES; CELL DEATH; CELLS, CULTURED; GROWTH SUBSTANCES; HUMANS; NEUTROPHILS; OXIDANTS; OXIDATION-REDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33645347969     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-005-9052-8     Document Type: Article

References (51)

1. Lee A., Whyte M.K. and Haslett C., Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J. Leukoc. Biol. 54: 283-288, 1993.
2. Price T.H., Chatta G.S. and Dale D.C., Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood 88: 335-340, 1996.
3. Dibbert B., Weber M., Nikolaizik W.H., Vogt P., Schoni M.H., Blaser K. and Simon H.U., Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: a general mechanism to accumulate effector cells in inflammation. Proc. Natl. Acad. Sci. USA 96: 13330-13335, 1999.
4. Hogg J.C., Neutrophil kinetics and lung injury. Physiol. Rev. 67: 1249-1295, 1987.
5. Savill J.S., Wyllie A.H., Henson J.E., Walport M.J., Henson P.M and Haslett C., Macrophage phagocytosis of aging neutrophils in inflammation. J. Clin. Invest. 83: 865-875, 1989.
6. Whyte M.K., Savill J., Meagher L.C., Lee A. and Haslett C., Coupling of neutrophil apoptosis to recognition by macrophages: coordinated acceleration by protein synthesis inhibitor. J. Leukoc. Biol. 62: 195-202, 1997.
7. Pongracz J., Webb P., Wang K., Deacon E., Lunn O.J. and Lord J.M., Spontaneous neutrophil apoptosis involves caspase 3-mediated activation of protein kinase C-delta. J. Biol. Chem. 274: 37329-37334, 1999.
8. Liles W.C., Kiener P.A., Ledbetter J.A., Aruffo A. and Klebanoff S.J., Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: Implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 184: 429-440, 1996.
9. Huang D.C., Hahne M., Schroeter M., Frei K., Fontana A., Villunger A., Newton K., Tschopp J. and Strasser A., Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L). Proc. Natl. Acad. Sci. USA 96: 14871-14876, 1999.
10. Kimura M., Haisa M., Uetsuka H., Takaoka M., Ohkawa T., Kawashima R., Yamatsuji T., Gunduz M., Kaneda Y., Tanaka N. and Naomoto Y., TNF combined with IFN-α accelerates NF-κ B-mediated apoptosis through enhancement of Fas expression in colon cancer cells. Cell Death Differ. 10: 718-728, 2003.
11. Murray J., Barbara J.A., Dunkley S.A., Lpoez A.F., Van Ostade X., Condliffe A.M., Dransfield I., Haslett C. and Chilvers E.R., Regulation of neutrophil apoptosis by tumor necrosis factor-alpha: requirement for TNFR55 and TNFR75 for induction of apoptosis in vitro. Blood 90: 2772-2783, 1997.
12. Salamone G., Giordano M., Trevani A.S., Gamberale R., Vermeulen M., Schettinni J. and Geffner J.R., Promotion of neutrophil apoptosis by TNF-alpha. J. Immunol. 166: 3476-3483, 2001.
13. Lorenzo H.K., Susin S.A., Penninger J. and Kroemer G., Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Differ. 6: 516-524, 1999.
14. +, cell shrinkage, and mitochondrial membrane potential during lymphocyte apoptosis. J. Biol. Chem. 274: 21953-21962, 1999.
15. Izban K.F., Ergin M., Huang Q., Qin J.Z., Martinez R.L., Schnitzer B., Ni H., Nickoloff B.J. and Alkan S., Characterization of NF-kappaB expression in Hodgkin's disease: inhibition of constitutively expressed NF-kappaB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells. Mod. Pathol. 14: 297-310, 2001.
16. Cummings B.S., Kinsey G.R., Bolchoz L.J. and Schnellmann R.G., Identification of caspase-independent apoptosis in epithelial and cancer cells. J. Pharmacol. Exp. Ther. 310: 126-134, 2004.
17. Kitanaka C. and Kuchino Y., Caspase-independent programmed cell death with necrotic morphology. Cell Death Differ. 6: 508-515, 1999.
18. Sperandio S., de Belle I. and Bredesen D.E., An alternative, nonapoptotic form of programmed cell death. Proc. Natl. Acad. Sci. USA 97: 14376-14381, 2000.
19. Formigli L., Papucci L., Tani A., Schiavone N., Tempestini A., Orlandini G.E., Capaccioli S. and Orlandini S.Z., Aponecrosis: morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis. J. Cell. Physiol. 182: 41-49, 2000.
20. Takei H., Araki A., Watanabe H., Ichinose A. and Sendo F., Rapid killing of human neutrophils by the potent activator phorbol 12-myristate 13-acetate (PMA) accompanied by changes different from typical apoptosis or necrosis. J. Leukoc. Biol. 59: 229-240, 1996.
21. Liu J., Akahoshi T., Jiang S., Namai R., Kitasato H., Endo H., Kameya T. and Kondo H., Induction of neutrophil death resembling neither apoptosis nor necrosis by ONO-AE-248, a selective agonist for PGE2 receptor subtype 3. J. Leukoc. Biol. 68: 187-193, 2000.
22. Liu C.Y., Takemasa A., Liles W.C., Goodman D.B., Jonas M., Rosen H., Chi E., Winn R.K., Harlan J.M. and Chuang P.I., Broad-spectrum caspase inhibition paradoxically augmented cell death in TNFa-stimulated neutrophils. Blood 101: 295-304, 2003.
23. von Gunten S., Yousefi S., Seitz M., Jakob S.M., Schaffner T., Seger R., Takala J., Villiger P.M. and Simon H.U., Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment. Blood 106: 1423-1431, 2005.
24. Pitrak D.L., Tsai H.C., Mullane K.M., Sutton S.H. and Stevens P., Accelerated neutrophil apoptosis in the acquired immunodeficiency syndrome. J. Clin. Invest. 98: 2714-2719, 1996.
25. Chilvers E.R., Rossi A.G., Murray J. and Haslett C., Regulation of granulocyte apoptosis and implications for anti-inflammatory therapy. Thorax 53: 533-534, 1998.
26. Squier M.K.T., Miller A.C.K., Malkinson A.M. and Cohen J.J., Calpain activation in apoptosis. J. Cell. Physiol. 159: 229-237, 1994.
27. Simon H.U., Neutrophil apoptosis pathways and their modification in inflammation. Immunol. Rev. 193: 101-110, 2003.
28. Akgul C., Moulding D.A. and Edwards S.W., Molecular control of neutrophil apoptosis. FEBS Lett. 487: 318-322, 2001.
29. Liu C.Y., Liu Y.H., Lin S.M., Yu C.T., Wang C.H., Lin H.C., Lin C.H. and Kuo H.P., Apoptotic neutrophils undergoing secondary necrosis induce human lung epithelial cell detachment. J. Biomed. Sci. 10: 746-756, 2003.
30. Lin H.C., Wang C.H., Liu C.Y., Yu C.T. and Kuo H.P., Erythromycin inhibits beta2-integrins (CD11b/CD18) expression, interleukin-8 release and intracellular oxidative metabolism in neutrophils. Respir. Med. 94: 654-660, 2000.
31. Wyllie A.H., Kerr J.F. and Currie A.R., Cell death: the significance of apoptosis. Int. Rev. Cytol. 68: 251-306, 1980.
32. Homburg C.H., de Haas M., von dem Borne A.E., Verhoeven A.J., Reutelingsperger C.P. and Roos D., Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood 85: 532-540, 1995.
33. Vercammen D., Beyaert R., Denecker G., Goossens V., Van Loo G., Declercq W., Grooten J., Fiers W. and Wandenabeele P., Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med. 187: 1477-1485, 1998.
34. Khwaja A. and Tatton L., Resistance to the cytotoxic effects of tumor necrosis factor alpha can be overcome by inhibition of a FADD/caspase-dependent signaling pathway. J. Biol. Chem. 274: 36817-36823, 1999.
35. Foghsgaard L., Wissing D., Mauch D., Mauch D., Lademann U., Bastholm L., Boes M., Elling F., Leist M. and Jaattela M., Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J. Cell Biol. 153: 999-1010, 2001.
36. Bortner C.D. and Cidlowski J.A., Caspase independent/dependent regulation of K(+), cell shrinkage, and mitochondrial membrane potential during lymphocyte apoptosis. J. Biol. Chem. 274: 21953-21962, 1999.
37. Kim S.O., Ono K. and Han J., Apoptosis by pan-caspase inhibitors in lipopolysaccharide-activated macrophages. Am. J. Physiol. Lung Cell Mol. Physiol. 281: L1095-L1105, 2001.
38. Izban K.F., Ergin M., Huang Q., Qin J.Z., Martinez R.L., Schnitzer B., Ni H., Nickoloff B.J. and Alkan S., Characterization of NF-kappaB expression in Hodgkin's disease: inhibition of constitutively expressed NF-kappaB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells. Mod Pathol. 14: 297-310, 2001.
39. Fadeel B., Ahlin A., Henter J.I., Orrenius S. and Hampton M.B., Involvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species. Blood 92: 4808-4818, 1998.
40. Nolan B., Duffy A., Paquin L., De M., Collette H., Graziano C.M. and Bankey P., Mitogen-activated protein kinases signal inhibition of apoptosis in lipopolysaccharide-stimulated neutrophils. Surgery 126: 406-412, 1999.
41. Lundqvist-Gustafsson H. and Bengtsson T., Activation of the granule pool of the NADPH oxidase accelerates apoptosis in human neutrophils. J. Leukoc. Biol. 65: 196-204, 1999.
42. Bass D.A., Parce J.W., Dechatelet L.R., Szejda P., Seeds M.C. and Thomas M., Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J. Immunol. 130: 1910-1917, 1983.
43. Babior B.M., NADPH oxidase: an update. Blood 93: 1464-1476, 1999.
44. Saido T.C., Sorimachi H. and Suzuki K., Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J. 8: 814-822, 1994.
45. Squier M.K.T., Sehnert A.J., Sellins K.S., Malkinson A.M., Takano E. and Cohen J.J., Calpain and calpastatin regulate neutrophil apoptosis. J. Cell. Physiol. 178: 311-319, 1999.
46. Nakagawa T., Nakagawa T. and Yuan J., Cross-talk between two cysteine protease families: activation of caspase-12 and calpain in apoptosis. J. Cell Biol. 150: 887-894, 2000.
47. Neumar R.W., Xu Y.A., Gada H., Guttmann R.P. and Siman R., Cross-talk between calpain and caspase proteolytic systems during neuronal apoptosis. J. Biol. Chem. 278: 14162-14167, 2003.
48. Wang K.K.W., Calpain and caspase: can you tell the difference?. Trends Neurosci. 23: 20-26, 2000.
49. Wei S., Liu J.H., Epling-Burnette P.K., Gamero A.M., Ussery D., Pearson E.W., Elkabani M.E., Diaz J.I. and Djeu J.Y., Critical role of Lyn kinase in inhibition of neutrophil apoptosis by granulocyte-macrophage colony-stimulating factor. J. Immunol. 157: 5155-5162, 1996.
50. Klein J.B., Rane M.J., Scherzer J.A., Coxon P.Y., Kettritz R., Mathiesen J.M., Buridi A. and McLeish K.R., Granulocyte-macrophage colony-stimulating factor delays neutrophil constitutive apoptosis through phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways. J. Immunol. 164: 4286-4291, 2000.
51. Suzuki K., Hino M., Hato F., Tatsumi N. and Kitagawa S., Cytokine-specific activation of distinct mitogen-activated protein kinase subtype cascades in human neutrophils stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor-alpha. Blood 93: 341-349, 1999.